PGI21 - Cost-effectiveness of treating Hepatitis C Virus (HCV) Genotype 1 (GT1) patients with abbvie 3D (Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir) +/- ribavirin compared to harvoni (Sofosbuvir/Ledipasvir) in the United States.

Authors :: Johnson, S.
Parise, H.
Virabhak, S.
Juday, T.
Misurski, D.
Marx, S.E.
Samp, J.C.
Source :: Value in Health. May2015, Vol. 18 Issue 3, pA225-A225. 1p.
Publication Year :: 2015

Subjects :: *HEPATITIS C treatment
*MEDICAL care costs
*GENOTYPES
*COST effectiveness
*RITONAVIR
*RIBAVIRIN

Full Text Access

Tools